Applications Built to Accelerate Cell Therapy Programs
Early activation and cell handling decisions shape more than experiments. They influence phenotype, reproducibility, process complexity, and how easily programs move from discovery into development and manufacturing.
StimulusBio technologies give cell therapy teams and platform partners precise, programmable control over cell activation and signaling, without genetic engineering. Our products and partnerships are designed to reduce downstream risk, support faster iteration, and keep workflows aligned as programs scale.
For Therapeutic Developers
Design activation strategies that hold up through development
Early activation choices influence phenotype balance, functional durability, and translational success. StimulusBio helps therapeutic developers make intentional activation decisions early, while preserving flexibility as program needs evolve.
CellPilot™ products enable developers to move beyond fixed, one-size-fits-all activation formats. Defined, programmable signal presentation supports rapid iteration, earlier phenotype insight, and activation strategies that can carry forward into process development. Whether teams need a standardized starting point or custom configuration, StimulusBio supports confident decision-making upstream, before conditions become locked.
For Cell Therapy Manufacturing
Activation strategies aligned with real-world process constraints
Manufacturing-ready workflows require more than strong expansion. Activation strategies must be reproducible, scalable, and compatible with evolving process and regulatory expectations.
StimulusBio activation products are designed with translation in mind. Bead-free formats, defined signal presentation, and simplified protocols reduce handling steps and variability while supporting consistent cell quality. This approach helps manufacturing teams evaluate performance without introducing unnecessary complexity and avoids platform changes as programs advance toward clinical-scale production.
For Tools and Instrument Manufacturers
Add biological control without rebuilding your platform
Cell therapy tools increasingly carry responsibility for biological outcomes, not just mechanical execution. Customers now expect systems to deliver reproducible biology, even when the platform is not sold as a reagent.
StimulusBio Inside enables tools and systems manufacturers to integrate defined, programmable immune signaling into existing platforms. This modular, non-genetic biological layer enhances differentiation and performance without requiring changes to core hardware, automation, or go-to-market strategy. Partners gain biological depth while maintaining ownership of the system and customer relationship.